Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Edwards Lifesciences Corp., consolidated balance sheet: assets (quarterly data)

US$ in thousands

	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017
Cash and cash equivalents	862,800)	1,506,900)	1,312,800)	1,174,200)	1,183,200)	1,024,000)	903,500)	662,900)	1,179,100)	1,186,600)	726,800)	709,200)	714,100)	1,261,300)	1,226,400)	1,227,000)	818,300)	630,300)	508,200)	819,300)
Short-term investments	604,000)	287,800)	248,400)	156,400)	219,400)	271,300)	260,300)	368,200)	337,800)	170,300)	207,500)	253,800)	242,400)	334,400)	174,400)	272,300)	519,200)	772,500)	623,600)	98,900)
Accounts receivable, net of allowances	582,200)	600,600)	640,500)	586,600)	514,600)	549,700)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Other receivables	82,700)	63,600)	59,800)	77,700)	88,200)	122,000)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Accounts and other receivables, net of allowances (legacy)	—)	—)	—)	—)	—)	—)	567,900)	585,100)	599,100)	570,000)	609,600)	578,000)	537,300)	530,100)	520,100)	446,800)	462,200)	475,000)	510,700)	510,200)
Inventories	726,700)	737,800)	759,500)	767,900)	802,300)	773,300)	735,100)	662,200)	640,900)	611,100)	624,900)	630,900)	607,000)	583,800)	568,100)	573,900)	554,900)	538,400)	491,600)	431,400)
Prepaid expenses	85,200)	76,900)	68,600)	77,300)	75,100)	68,600)	57,300)	65,800)	59,100)	57,300)	55,700)	55,400)	54,300)	52,600)	69,900)	78,000)	60,600)	52,800)	54,100)	53,000)
Other current assets	237,100)	241,900)	233,300)	229,100)	208,200)	171,500)	166,200)	163,700)	168,000)	144,400)	130,200)	141,500)	131,800)	150,400)	137,100)	118,900)	116,900)	97,400)	95,200)	105,600)
Current assets	3,180,700)	3,515,500)	3,322,900)	3,069,200)	3,091,000)	2,980,400)	2,690,300)	2,507,900)	2,984,000)	2,739,700)	2,354,700)	2,368,800)	2,286,900)	2,912,600)	2,696,000)	2,716,900)	2,532,100)	2,566,400)	2,283,400)	2,018,400)
Long-term investments	1,834,200)	1,282,000)	1,014,200)	802,200)	801,600)	599,000)	594,400)	587,800)	585,500)	386,000)	412,900)	453,700)	506,300)	479,000)	470,400)	532,100)	567,000)	567,500)	551,500)	519,000)
Property, plant, and equipment, net	1,546,600)	1,464,600)	1,445,800)	1,417,900)	1,395,200)	1,276,300)	1,195,600)	1,100,600)	1,060,300)	973,600)	931,100)	892,200)	867,500)	826,100)	770,200)	711,600)	679,700)	649,600)	627,900)	588,800)
Operating lease right-of-use assets	92,100)	84,800)	84,600)	88,500)	94,200)	89,500)	84,700)	75,500)	80,100)	73,300)	71,200)	69,900)	—)	—)	—)	—)	—)	—)	—)	—)
Goodwill	1,167,900)	1,170,400)	1,171,800)	1,170,800)	1,173,200)	1,170,000)	1,167,700)	1,166,200)	1,167,700)	1,156,600)	1,173,900)	1,103,400)	1,112,200)	1,122,300)	1,118,600)	1,144,800)	1,126,500)	980,500)	965,100)	945,200)
Other intangible assets, net	323,600)	325,300)	327,000)	330,300)	331,400)	332,400)	333,500)	334,800)	336,500)	381,100)	385,600)	341,300)	343,200)	467,900)	466,000)	480,500)	468,000)	414,900)	408,600)	402,100)
Deferred income taxes	246,700)	184,000)	190,500)	209,300)	230,900)	215,200)	204,100)	158,000)	172,200)	155,800)	163,800)	164,500)	174,000)	115,100)	130,100)	181,400)	213,600)	197,100)	185,200)	179,100)
Other assets	110,800)	133,700)	105,300)	125,500)	119,600)	138,000)	153,800)	145,300)	101,800)	100,200)	80,300)	75,500)	33,600)	35,200)	34,800)	57,800)	108,900)	112,400)	116,800)	127,800)
Long-term assets	5,321,900)	4,644,800)	4,339,200)	4,144,500)	4,146,100)	3,820,400)	3,733,800)	3,568,200)	3,504,100)	3,226,600)	3,218,800)	3,100,500)	3,036,800)	3,045,600)	2,990,100)	3,108,200)	3,163,700)	2,922,000)	2,855,100)	2,762,000)
Total assets	8,502,600)	8,160,300)	7,662,100)	7,213,700)	7,237,100)	6,800,800)	6,424,100)	6,076,100)	6,488,100)	5,966,300)	5,573,500)	5,469,300)	5,323,700)	5,958,200)	5,686,100)	5,825,100)	5,695,800)	5,488,400)	5,138,500)	4,780,400)

Cash and cash equivalents: The cash and cash equivalents values demonstrate a volatile pattern throughout the observed periods. Initially, there is a decline from US$819.3 million in March 2017 to US$508.2 million in June 2017, followed by fluctuations that culminate in a peak of approximately US$1.26 billion in September 2018. Post this peak, the value generally decreases until a trough around March 2020 (US$662.9 million). From this point onward, it rises again, reaching a high of US$1.5 billion in September 2021 before sharply dropping to US$862.8 million by December 2021.
Short-term investments: Short-term investments present significant variation without a consistent trend. Starting at US$98.9 million in March 2017, they rise sharply to US$623.6 million by June 2017 and US$772.5 million in September 2017. Thereafter, they decline somewhat erratically until a low of US$174.4 million in June 2018. The amount fluctuates modestly between US$200 million and US$370 million up to December 2020, before strong growth resumes in 2021, culminating in a peak of US$604 million by December 2021.
Accounts receivable, net of allowances: Data for this item is only available from March 2020 onward, showing rising values from US$549.7 million at the start to US$640.5 million in December 2020, followed by slight fluctuations. By December 2021, it stands at US$582.2 million. This suggests a relative stabilization or slight fall towards the end of the period.
Other receivables: Availability is limited to the period after March 2020. The balances show a downward trend from US$122 million in March 2020 to US$59.8 million in December 2020, followed by modest recovery toward the end of 2021, reaching US$82.7 million as of December.
Accounts and other receivables, net of allowances (legacy): This category shows a general decline from US$510.2 million in March 2017 to US$567.9 million by June 2020. The data series ends thereafter, suggesting either a reclassification or discontinuation. Overall, values maintain a stable range around US$450 million to US$600 million.
Inventories: Inventory levels increase steadily over the entire span, from US$431.4 million in March 2017 to a peak of US$802.3 million in December 2020, followed by a moderate decline in 2021, ending at US$726.7 million. This indicates an expansion in stock holdings, possibly due to business growth or strategic stockpiling.
Prepaid expenses: Prepaid expenses modestly increase across time, beginning at US$53 million in March 2017, with a small dip and recovery between 2018 and early 2019, reaching a maximum of US$85.2 million by December 2021. The general upward trend suggests growing upfront payments or service prepayments.
Other current assets: This item shows a trend of gradual increase, moving from approximately US$105.6 million in March 2017 to US$237.1 million by December 2021, suggesting expansion or accumulation in miscellaneous current assets over the period.
Current assets: Overall current assets show significant growth from US$2.02 billion in March 2017 to peaks exceeding US$3.5 billion in late 2021. The trend is generally upward with periodic fluctuations, indicating growing liquidity and short-term resources.
Long-term investments: Long-term investments fluctuate considerably, starting at US$519 million in March 2017, dipping to approximately US$386 million in late 2019, but then escalating sharply to reach US$1.83 billion by December 2021. This reflects a strategic shift toward increasing long-term investment holdings in recent years.
Property, plant, and equipment, net: The net value of property, plant, and equipment consistently increases throughout the period, growing from US$588.8 million in March 2017 to US$1.55 billion by December 2021, highlighting ongoing capital investments and asset base expansion.
Operating lease right-of-use assets: Data for operating lease ROU assets is only available commencing late 2018 (US$69.9 million) and shows a moderate increase through 2021, reaching approximately US$92.1 million by the end of 2021. This likely reflects the adoption of updated leasing accounting standards and an increase in leased assets.
Goodwill: Goodwill remains relatively stable, starting at US$945.2 million in March 2017, rising steadily to about US$1.16 billion by 2019, and maintaining this level with minor fluctuations around US$1.17 billion through to the end of 2021. This suggests stable acquisition activity or impairment management.
Other intangible assets, net: Other intangible assets exhibit a declining trend, decreasing from US$402.1 million in March 2017 to US$323.6 million by December 2021, reflecting amortization or impairment of intangible assets over time.
Deferred income taxes: Deferred income taxes demonstrate fluctuations with no clear trend. Starting at approximately US$179.1 million in early 2017, figures dip mid-period before increasing again in recent years, reaching US$246.7 million by December 2021. The variability may be influenced by tax planning or timing differences.
Other assets: Other assets generally remain in the range of approximately US$34.8 million to US$145.3 million, with a notable increase in early 2020 followed by varying amounts and generally moderate fluctuations through 2021. This suggests episodic changes in miscellaneous asset categories.
Long-term assets: The total of long-term assets increases steadily from US$2.76 billion in March 2017 to over US$5.32 billion in December 2021. This indicates substantial growth in the company’s capital and noncurrent asset base across multiple categories.
Total assets: Total assets also show a consistent upward trajectory, climbing from US$4.78 billion in March 2017 to US$8.5 billion by December 2021. Despite some quarter-to-quarter fluctuations, the overall expansion reflects significant asset growth and accumulation over the period.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Edwards Lifesciences Corp. (NYSE:EW)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data